Cue Biopharma, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2017 to Q2 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Cue Biopharma, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2017 to Q2 2024.
- Cue Biopharma, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$10.2M, a 22.9% increase year-over-year.
- Cue Biopharma, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$47M, a 9.42% increase year-over-year.
- Cue Biopharma, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$50.7M, a 4.3% increase from 2022.
- Cue Biopharma, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$53M, a 20% decline from 2021.
- Cue Biopharma, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$44.2M, a 1.39% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)